1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Tomizawa, T. Koshiba, S. Watanabe, S. Harada, T. Kigawa, T. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structure of the 13th filamin domain from human Filamin-B 10.2210/pdb2dj4/pdb pdb_00002dj4 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11197.574 Filamin-B Filamin domain 1 man polymer FLN-B, Beta-filamin, Actin-binding-like protein, Thyroid autoantigen, Truncated actin-binding protein, Truncated ABP, ABP-280 homolog, ABP-278, Filamin 3, Filamin homolog 1, Fh1 no no GSSGSSGVVDPSKVKIAGPGLGSGVRARVLQSFTVDSSKAGLAPLEVRVLGPRGLVEPVNVVDNGDGTHTVTYTPSQEGP YMVSVKYADEEIPRSPFKVKVLPTYDAS GSSGSSGVVDPSKVKIAGPGLGSGVRARVLQSFTVDSSKAGLAPLEVRVLGPRGLVEPVNVVDNGDGTHTVTYTPSQEGP YMVSVKYADEEIPRSPFKVKVLPTYDAS A hsk003002600.6 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis FLNB 9606 Homo sapiens Cell free synthesis PLASMID P060123-13 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-10-01 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details Y PDBJ Y PDBJ 2006-03-31 REL REL target function, structures with the lowest energy, structures with the least restraint violations 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 296 K torsion angle dynamics, restrainted molecular dynamics 1 lowest energy 1.16mM Filamin domain U-15N,13C; 20mM d-Tris-HCl(pH 7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O 90% H2O/10% D2O Bruker collection TopSpin 1.3 Delaglio, F. processing NMRPipe 20060324 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.9742 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 900 Bruker AVANCE II GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A VAL 8 n 8 VAL 8 A VAL 9 n 9 VAL 9 A ASP 10 n 10 ASP 10 A PRO 11 n 11 PRO 11 A SER 12 n 12 SER 12 A LYS 13 n 13 LYS 13 A VAL 14 n 14 VAL 14 A LYS 15 n 15 LYS 15 A ILE 16 n 16 ILE 16 A ALA 17 n 17 ALA 17 A GLY 18 n 18 GLY 18 A PRO 19 n 19 PRO 19 A GLY 20 n 20 GLY 20 A LEU 21 n 21 LEU 21 A GLY 22 n 22 GLY 22 A SER 23 n 23 SER 23 A GLY 24 n 24 GLY 24 A VAL 25 n 25 VAL 25 A ARG 26 n 26 ARG 26 A ALA 27 n 27 ALA 27 A ARG 28 n 28 ARG 28 A VAL 29 n 29 VAL 29 A LEU 30 n 30 LEU 30 A GLN 31 n 31 GLN 31 A SER 32 n 32 SER 32 A PHE 33 n 33 PHE 33 A THR 34 n 34 THR 34 A VAL 35 n 35 VAL 35 A ASP 36 n 36 ASP 36 A SER 37 n 37 SER 37 A SER 38 n 38 SER 38 A LYS 39 n 39 LYS 39 A ALA 40 n 40 ALA 40 A GLY 41 n 41 GLY 41 A LEU 42 n 42 LEU 42 A ALA 43 n 43 ALA 43 A PRO 44 n 44 PRO 44 A LEU 45 n 45 LEU 45 A GLU 46 n 46 GLU 46 A VAL 47 n 47 VAL 47 A ARG 48 n 48 ARG 48 A VAL 49 n 49 VAL 49 A LEU 50 n 50 LEU 50 A GLY 51 n 51 GLY 51 A PRO 52 n 52 PRO 52 A ARG 53 n 53 ARG 53 A GLY 54 n 54 GLY 54 A LEU 55 n 55 LEU 55 A VAL 56 n 56 VAL 56 A GLU 57 n 57 GLU 57 A PRO 58 n 58 PRO 58 A VAL 59 n 59 VAL 59 A ASN 60 n 60 ASN 60 A VAL 61 n 61 VAL 61 A VAL 62 n 62 VAL 62 A ASP 63 n 63 ASP 63 A ASN 64 n 64 ASN 64 A GLY 65 n 65 GLY 65 A ASP 66 n 66 ASP 66 A GLY 67 n 67 GLY 67 A THR 68 n 68 THR 68 A HIS 69 n 69 HIS 69 A THR 70 n 70 THR 70 A VAL 71 n 71 VAL 71 A THR 72 n 72 THR 72 A TYR 73 n 73 TYR 73 A THR 74 n 74 THR 74 A PRO 75 n 75 PRO 75 A SER 76 n 76 SER 76 A GLN 77 n 77 GLN 77 A GLU 78 n 78 GLU 78 A GLY 79 n 79 GLY 79 A PRO 80 n 80 PRO 80 A TYR 81 n 81 TYR 81 A MET 82 n 82 MET 82 A VAL 83 n 83 VAL 83 A SER 84 n 84 SER 84 A VAL 85 n 85 VAL 85 A LYS 86 n 86 LYS 86 A TYR 87 n 87 TYR 87 A ALA 88 n 88 ALA 88 A ASP 89 n 89 ASP 89 A GLU 90 n 90 GLU 90 A GLU 91 n 91 GLU 91 A ILE 92 n 92 ILE 92 A PRO 93 n 93 PRO 93 A ARG 94 n 94 ARG 94 A SER 95 n 95 SER 95 A PRO 96 n 96 PRO 96 A PHE 97 n 97 PHE 97 A LYS 98 n 98 LYS 98 A VAL 99 n 99 VAL 99 A LYS 100 n 100 LYS 100 A VAL 101 n 101 VAL 101 A LEU 102 n 102 LEU 102 A PRO 103 n 103 PRO 103 A THR 104 n 104 THR 104 A TYR 105 n 105 TYR 105 A ASP 106 n 106 ASP 106 A ALA 107 n 107 ALA 107 A SER 108 n 108 SER 108 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 15 A N LYS 15 A O ASP 36 A O ASP 36 A N GLN 31 A N GLN 31 A O TYR 73 A O TYR 73 A O THR 70 A O THR 70 A N VAL 62 A N VAL 62 A O GLU 57 A O GLU 57 A N VAL 49 A N VAL 49 A N LEU 50 A N LEU 50 A O MET 82 A O MET 82 A N GLY 79 A N GLY 79 A O VAL 101 A O VAL 101 1 A PRO 75 -69.73 97.12 1 A PRO 80 -69.78 88.07 1 A GLU 91 -54.54 109.50 1 A ILE 92 -47.52 152.95 1 A PRO 93 -69.74 3.93 1 A PRO 96 -69.70 -179.97 1 A THR 104 -34.70 -34.51 2 A SER 3 36.77 42.26 2 A PRO 75 -69.74 90.45 2 A PRO 80 -69.83 86.59 2 A ILE 92 -49.24 153.20 2 A PRO 93 -69.65 4.41 2 A THR 104 -36.34 -30.42 2 A ALA 107 -111.66 78.73 3 A SER 6 -69.48 90.54 3 A PRO 75 -69.73 91.90 3 A PRO 80 -69.72 90.85 3 A PRO 93 -69.76 4.29 3 A PRO 96 -69.69 -179.41 3 A THR 104 -33.97 -36.21 4 A PRO 75 -69.77 98.12 4 A PRO 80 -69.78 92.76 4 A ASP 89 74.22 31.74 4 A PRO 93 -69.80 4.47 4 A THR 104 -35.21 -31.75 5 A PRO 11 -69.76 1.49 5 A PRO 75 -69.76 92.92 5 A PRO 80 -69.76 89.13 5 A TYR 87 -160.44 110.54 5 A GLU 91 -54.39 108.38 5 A ILE 92 -46.90 153.02 5 A PRO 93 -69.74 4.68 5 A PRO 96 -69.72 -178.53 5 A THR 104 -34.83 -35.32 6 A PRO 75 -69.80 95.04 6 A PRO 80 -69.76 89.15 6 A PRO 93 -69.74 4.74 6 A PRO 96 -69.69 -179.92 6 A THR 104 -34.83 -32.19 6 A TYR 105 -90.05 38.71 6 A ALA 107 -108.41 78.53 7 A PRO 11 -69.74 0.78 7 A PRO 80 -69.78 93.93 7 A ASP 89 73.47 31.40 7 A GLU 91 -53.36 107.90 7 A ILE 92 -45.93 153.00 7 A PRO 93 -69.75 4.31 7 A THR 104 -35.58 -32.15 7 A ALA 107 -79.87 43.45 8 A PRO 75 -69.73 91.39 8 A PRO 80 -69.72 86.19 8 A TYR 87 -160.18 109.47 8 A ILE 92 -49.41 153.03 8 A PRO 93 -69.74 3.85 8 A THR 104 -36.11 -30.82 8 A ALA 107 -81.91 44.03 9 A VAL 8 -33.97 135.73 9 A PRO 11 -69.81 0.37 9 A PRO 75 -69.75 94.59 9 A PRO 80 -69.78 90.13 9 A ASP 89 71.04 33.50 9 A PRO 93 -69.68 4.33 9 A THR 104 -34.12 -33.40 9 A ALA 107 -68.02 81.87 10 A PRO 11 -69.76 0.30 10 A PRO 75 -69.81 94.39 10 A PRO 80 -69.65 93.90 10 A PRO 93 -69.66 5.83 10 A THR 104 -39.38 -27.48 10 A TYR 105 -82.25 38.54 10 A ASP 106 36.44 29.37 11 A PRO 75 -69.75 94.52 11 A SER 76 -39.38 -27.20 11 A PRO 80 -69.71 81.66 11 A PRO 93 -69.74 6.20 11 A THR 104 -33.87 -35.05 12 A SER 6 -83.00 40.00 12 A VAL 8 -42.99 155.74 12 A PRO 75 -69.74 92.97 12 A PRO 80 -69.68 84.20 12 A PRO 93 -69.68 4.34 12 A THR 104 -34.73 -32.67 13 A PRO 75 -69.73 94.38 13 A PRO 80 -69.74 83.24 13 A PRO 93 -69.80 6.02 13 A THR 104 -33.96 -34.94 13 A ALA 107 -68.06 82.92 14 A SER 6 34.65 42.14 14 A PRO 75 -69.74 99.01 14 A PRO 80 -69.80 92.49 14 A ILE 92 -49.50 152.86 14 A PRO 93 -69.83 4.11 14 A THR 104 -39.02 -25.66 14 A ASP 106 -164.53 113.27 14 A ALA 107 -104.68 43.68 15 A SER 3 -104.27 42.59 15 A PRO 75 -69.73 89.09 15 A PRO 80 -69.71 86.45 15 A PRO 93 -69.80 5.15 15 A THR 104 -34.61 -32.87 16 A VAL 8 -38.10 152.34 16 A PRO 11 -69.74 3.11 16 A PRO 75 -69.76 93.42 16 A PRO 80 -69.72 93.71 16 A ASP 89 71.40 30.73 16 A PRO 93 -69.86 4.27 16 A THR 104 -39.60 -30.33 17 A SER 6 -88.70 42.15 17 A PRO 75 -69.82 93.99 17 A PRO 80 -69.98 91.24 17 A PRO 93 -69.82 4.89 17 A THR 104 -34.01 -33.25 17 A TYR 105 -81.82 48.09 17 A ASP 106 -90.19 35.93 17 A ALA 107 -81.23 41.63 18 A SER 6 -93.26 43.15 18 A PRO 75 -69.81 90.22 18 A PRO 80 -69.73 89.87 18 A PRO 93 -69.75 5.72 18 A THR 104 -35.24 -31.89 18 A ALA 107 -84.81 41.26 19 A SER 3 -45.42 163.93 19 A PRO 75 -69.79 93.30 19 A PRO 80 -69.84 83.45 19 A PRO 93 -69.77 4.69 19 A PRO 96 -69.80 -178.83 19 A THR 104 -34.12 -35.21 19 A ALA 107 -90.76 36.31 20 A PRO 11 -69.74 2.40 20 A PRO 75 -69.69 94.62 20 A PRO 80 -69.75 84.06 20 A PRO 93 -69.73 8.30 20 A THR 104 -33.87 -36.16 20 A ALA 107 -88.18 41.61 Solution structure of the 13th filamin domain from human Filamin-B 1 N N STRUCTURAL PROTEIN beta-sandwich, immunoglobulin-like fold, filamin domain, NPPSFA, National Project on Protein Structural and Functional Analyses, Structural Genomics, RIKEN Structural Genomics/Proteomics Initiative, RSGI, STRUCTURAL PROTEIN A SER 95 A SER 95 1 A PRO 96 A PRO 96 -0.10 A SER 95 A SER 95 2 A PRO 96 A PRO 96 -0.01 A SER 95 A SER 95 3 A PRO 96 A PRO 96 -0.13 A SER 95 A SER 95 4 A PRO 96 A PRO 96 0.08 A SER 95 A SER 95 5 A PRO 96 A PRO 96 -0.08 A SER 95 A SER 95 6 A PRO 96 A PRO 96 -0.11 A SER 95 A SER 95 7 A PRO 96 A PRO 96 -0.12 A SER 95 A SER 95 8 A PRO 96 A PRO 96 0.02 A SER 95 A SER 95 9 A PRO 96 A PRO 96 -0.05 A SER 95 A SER 95 10 A PRO 96 A PRO 96 -0.02 A SER 95 A SER 95 11 A PRO 96 A PRO 96 -0.03 A SER 95 A SER 95 12 A PRO 96 A PRO 96 -0.05 A SER 95 A SER 95 13 A PRO 96 A PRO 96 0.11 A SER 95 A SER 95 14 A PRO 96 A PRO 96 -0.05 A SER 95 A SER 95 15 A PRO 96 A PRO 96 0.02 A SER 95 A SER 95 16 A PRO 96 A PRO 96 0.02 A SER 95 A SER 95 17 A PRO 96 A PRO 96 -0.02 A SER 95 A SER 95 18 A PRO 96 A PRO 96 -0.05 A SER 95 A SER 95 19 A PRO 96 A PRO 96 0.09 A SER 95 A SER 95 20 A PRO 96 A PRO 96 0.02 FLNB_HUMAN UNP 1 1418 O75369 1418 1518 2DJ4 8 108 O75369 A 1 8 108 1 cloning artifact GLY 1 2DJ4 A O75369 UNP 1 1 cloning artifact SER 2 2DJ4 A O75369 UNP 2 1 cloning artifact SER 3 2DJ4 A O75369 UNP 3 1 cloning artifact GLY 4 2DJ4 A O75369 UNP 4 1 cloning artifact SER 5 2DJ4 A O75369 UNP 5 1 cloning artifact SER 6 2DJ4 A O75369 UNP 6 1 cloning artifact GLY 7 2DJ4 A O75369 UNP 7 1 MET SEE REMARK 999 VAL 61 2DJ4 A O75369 UNP 1471 61 4 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LYS 15 A LYS 15 A ALA 17 A ALA 17 A GLN 31 A GLN 31 A ASP 36 A ASP 36 A THR 68 A THR 68 A TYR 73 A TYR 73 A VAL 62 A VAL 62 A ASP 63 A ASP 63 A VAL 56 A VAL 56 A GLU 57 A GLU 57 A LEU 45 A LEU 45 A LEU 50 A LEU 50 A GLY 79 A GLY 79 A TYR 87 A TYR 87 A PHE 97 A PHE 97 A VAL 101 A VAL 101